H.R.7567 To amend the Federal Food, Drug, and Cosmetic Act to improve the treatment of rare diseases and conditions, and for other purposes.
Sponsored by Paul Tonko (D). Introduced on 2020-07-09 in the House Energy and Commerce Committee. The last major action was Referred to the House Committee on Energy and Commerce which took place on 2020-07-09.
The full legislation document not yet available.
This legislation was co-sponsored by David McKinley (R).
07/09/2020 - Referred to the House Committee on Energy and Commerce.